The MOTION study: Two-year results of a real-world randomized controlled trial of the mild® procedure for treatment of lumbar spinal stenosis

被引:1
作者
Deer, Timothy R. [1 ,8 ]
Chafin, Timothy B. [2 ]
Costandi, Shrif J. [3 ]
Qu, Huaguang [4 ]
Kim, Christopher [1 ]
Jassal, Navdeep [5 ]
Patel, Kiran [6 ]
Calodney, Aaron [7 ]
机构
[1] Spine & Nerve Ctr Virginias, Charleston, WV USA
[2] Vidant Roanoke Chowan Hosp, Ahoskie, NC USA
[3] Cleveland Clin, Cleveland, OH USA
[4] Penn Pain & Spine Inst, Chalfont, PA USA
[5] Excel Pain & Spine, Lakeland, FL 33805 USA
[6] Spine & Pain Inst New York, New Hyde Pk, NY USA
[7] Precis Spine Care, Tyler, TX USA
[8] Spine & Nerve Ctr Virginias, 400 Court St, Suite 100, Charleston, WV 25301 USA
关键词
CMM; hypertrophic ligamentum flavum; low back pain; lumbar spinal stenosis; mild; neurogenic claudication; LOW-BACK-PAIN; MILD(R) PROCEDURE; DECOMPRESSION; OUTCOMES; INJECTIONS;
D O I
10.1111/papr.13293
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective: The MOTION study is designed to measure the impact of percutaneous image-guided lumbar decompression as a first-line therapy on patients otherwise receiving real-world conventional medical management for lumbar spinal stenosis with neurogenic claudication secondary to hypertrophic ligamentum flavum. This prospective, multicenter randomized controlled trial uses objective and patient-reported outcome measures to compare the combination of the mild (R) percutaneous treatment and nonsurgical conventional medical management (CMM) to CMM-Alone. Methods: Test group patients received the mild procedure after study enrollment. Test and control groups were allowed conventional conservative therapies and low-risk interventional therapies as recommended by their physicians. Subjective outcomes included the Oswestry Disability Index, Numeric Pain Rating Scale, and Zurich Claudication Questionnaire. Objective outcomes included a validated Walking Tolerance Test, the rate of subsequent lumbar spine interventions, and safety data. Results: Two-year follow-up included 64 mild + CMM and 67 CMM-Alone patients. All outcome measures showed significant improvement from baseline for mild + CMM, whereas the majority of CMM-Alone patients had elected to receive mild treatment or other lumbar spine interventions by 2 years, precluding valid 2-year between-group comparisons. Neither group reported any device-or procedure-related adverse events. Conclusions: The durability of mild + CMM for this patient population was demonstrated for all efficacy outcomes through 2 years. Improvements in walking time from baseline to 2 years for patients treated with mild + CMM were significant and substantial. The lack of reported device or procedure-related adverse events reinforces the strong safety profile of the mild procedure. These results provide support for early interventional treatment of symptomatic LSS with the mild procedure.
引用
收藏
页码:109 / 119
页数:11
相关论文
共 35 条
  • [1] Abdi Salahadin, 2007, Pain Physician, V10, P185
  • [2] Arbit E, 2001, CLIN ORTHOP RELAT R, P137
  • [3] Benyamin RM, 2016, PAIN PHYSICIAN, V19, P229
  • [4] Non-operative treatment of lumbar spinal stenosis
    Beyer, Frank
    Geier, Fabian
    Bredow, Jan
    Oppermann, Johannes
    Schmidt, Andreas
    Eysel, Peer
    Sobottke, Rolf
    [J]. TECHNOLOGY AND HEALTH CARE, 2016, 24 (04) : 551 - 557
  • [5] A matter of perspective - Objective versus subjective outcomes in the assessment of quality of recovery
    Bowyer, Andrea
    Royse, Colin
    [J]. BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY, 2018, 32 (3-4) : 287 - 294
  • [6] A Double-blind, Randomized, Prospective Study of Epidural Steroid Injection vs. The mild® Procedure in Patients with Symptomatic Lumbar Spinal Stenosis
    Brown, Lora L.
    [J]. PAIN PRACTICE, 2012, 12 (05) : 333 - 341
  • [7] Long-term Results of Percutaneous Lumbar Decompression for LSS Two-Year Outcomes
    Chopko, Bohdan W.
    [J]. CLINICAL JOURNAL OF PAIN, 2013, 29 (11) : 939 - 943
  • [8] MEASUREMENT OF EXERCISE TOLERANCE ON THE TREADMILL IN PATIENTS WITH SYMPTOMATIC LUMBAR SPINAL STENOSIS - A USEFUL INDICATOR OF FUNCTIONAL STATUS AND SURGICAL OUTCOME
    DEEN, HG
    ZIMMERMAN, RS
    LYONS, MK
    MCPHEE, MC
    VERHEIJDE, JL
    LEMENS, SM
    [J]. JOURNAL OF NEUROSURGERY, 1995, 83 (01) : 27 - 30
  • [9] Objective Real-World Outcomes of Patients Suffering from Painful Neurogenic Claudication Treated with the mild® Procedure: Interim 6-Month Report of a Randomized Controlled Trial
    Deer, Timothy
    Kim, Christopher
    Wahezi, Sayed Emal
    Qu, Huaguang
    Sayed, Dawood
    [J]. JOURNAL OF PAIN RESEARCH, 2021, 14 : 1687 - 1697
  • [10] Best Practices for Minimally Invasive Lumbar Spinal Stenosis Treatment 2.0 (MIST): Consensus Guidance from the American Society of Pain and Neuroscience (ASPN)
    Deer, Timothy R.
    Grider, Jay S.
    Pope, Jason E.
    Lamer, Tim J.
    Wahezi, Sayed E.
    Hagedorn, Jonathan M.
    Falowski, Steven
    Tolba, Reda
    Shah, Jay M.
    Strand, Natalie
    Escobar, Alex
    Malinowski, Mark
    Bux, Anjum
    Jassal, Navdeep
    Hah, Jennifer
    Weisbein, Jacqueline
    Tomycz, Nestor D.
    Jameson, Jessica
    Petersen, Erika A.
    Sayed, Dawood
    [J]. JOURNAL OF PAIN RESEARCH, 2022, 15 : 1325 - 1354